Form 8-K - Current report:
SEC Accession No. 0001683168-24-001042
Filing Date
2024-02-16
Accepted
2024-02-16 12:02:25
Documents
15
Period of Report
2024-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT canna_8k.htm   iXBRL 8-K 32830
2 SUPPLY AGREEMENT BETWEEN CANNAPHARMARX, INC. AND D.N.S. CANTEK 2019 LTD DATED FE canna_ex0101.htm EX-1.1 7913
  Complete submission text file 0001683168-24-001042.txt   219735

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cpmd-20240215.xsd EX-101.SCH 3030
4 XBRL LABEL FILE cpmd-20240215_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cpmd-20240215_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT canna_8k_htm.xml XML 3726
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 24646665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)